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Background: Complementary and alternative medicine (CAM) is extensively used in patients with
allergic diseases worldwide. The purpose of this study was to investigate the actual situation of CAM
practice in the treatment of allergic rhinitis.
Methods: We distributed questionnaires to otolaryngologists at 114 facilities in Japan. The subjects who
participated in this study included children <16 years of age and adults 16 years of age diagnosed with
allergic rhinitis by otolaryngologists. The survey was performed in the period from September 2007 to
August 2009. Furthermore, we performed the same investigation out of the hospital setting, such as
during general health examinations. All questionnaires were returned to Chiba University and analyzed.
Results: The proportions of patients who had ever experimented with CAM in the hospital survey were
7.1% (225/3170) and 19.2% (1416/7363) of children and adults, respectively. Approximately 36.2% of the
adult patients thought that the treatments were effective. The main reasons for CAM use were safety,
convenience and low price. However, the group who spent more than $1000 on CAM felt more dissat-
isfaction and anxiety related to treatment at the hospital. The situation of CAM practice was not
consistent and was instead inﬂuenced by the backgrounds of the subjects.
Conclusions: Many patients who receive CAM report feeling that the effects of treatment provided by
hospitals are insufﬁcient and have concerns about the side effects of such treatments. Information
regarding standard treatments, as described in the guidelines, should become widely known and
diffused, and strong communication with patients should be considered.
Copyright © 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).logy, Head and Neck Surgery,
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Forms of complementary and alternative medicine (CAM) are
extensively used worldwide. CAM is deﬁned as “a group of diverse
medical and health care systems, therapies and products that arevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Table 1
The contents of the questionnaire.
No. Questionnaire items
1 Had you ever used CAM therapies for allergic rhinitis? (yes/no)
2 What types of CAM have you ever used? Multiple answers are possible.
[Following 23 items: Ten-Cha (Rubus suavissimus); Chameleon plant tea
(Houttuynia cordata); Guava tea (Psidium guajava); Japanese green tea
(Camellia sinensis); Japanese persimmon tea (Diospyros kaki); Gymnema tea
(Gymnema sylvestre); Herb tea; Shiso (Perilla frutescens); Green juice;
Chlorella; Aloe; Acupuncture; Moxibustion; Chinese medicine; Foods
containing lactic acid bacteria (such as yogurt); Cedar pollen candy; Mint
gum; Tablet containing lactic acid bacteria; Propolis; Nose steam therapy;
Aromatherapy; Spa therapy; Others]
3 Tell the period of use of a CAM which was used for the longest time.
[Less than one month; Approximately half one year; Approximately one
year; More than one year; Others]
4 How was the efﬁcacy of a CAM which was used for the longest time?
[Unknown; Ineffective; Slightly effective; Very effective; Others]
5 How much had you spent on CAM therapies?
[Under $10; $10e100; $100e1000; More than $1000; Others]
6 What were the reasons why you began CAM therapies? Multiple answers
are possible.
[Few side effects; Convenience; Low price; Dissatisfaction with the
treatment at the hospital; Worry about the side effects of the treatment at
the hospital; Insufﬁcient treatment explanation from the physician; Others]
7 What or who were the providers of CAM information? Multiple answers are
possible.
[TV or newspaper; Family or friends; Health magazines; Website use;
Physicians; Others]
8 Had you ever talked about CAM therapies with physicians? [yes/no]
9 How was the reaction of the physicians when you talked about CAM
therapies?
[Physicians recommended to continue using your CAM treatments;
Physicians encouraged to stop using your CAM treatments; No advice]
S. Yonekura et al. / Allergology International xxx (2016) 1e72often not integrated with conventional medicines”.1 The number of
CAM therapies is enormous, and the treatments differ by country,
race, culture, religion, history and the prevalence of various dis-
eases. Data compiled from public opinion surveys conducted be-
tween 1985 and 1992 show rates of CAM use in the general
population of 26% in the United Kingdom, 49% in France, 46% in
Germany and 34% in the United States.2 A follow-up national survey
performed in the United States revealed that the use of CAM
increased from 33.8% in 1990 to 42.1% in 1997.3
The prevalence of CAM use is high among patients with chronic
diseases.4 Allergic diseases, including asthma and allergic rhinitis,
are common chronic conditions, and CAM therapies are also
extensively used in the treatment of allergic diseases. A population-
based survey in the United States conducted in 1999 reported the
prevalence of CAM use among adults with asthma or rhinosinusitis
to be 42%.5 In another survey conducted from 2000 to 2001, 26.5%
of the participants used CAM treatments for their allergies
(Germany).6
In recent years, many countries have experienced an increase in
the prevalence of allergic rhinitis.7 There are many reports evalu-
ating the efﬁcacy of various CAM therapies for allergic rhinitis, such
as acupuncture,8e10 herbal medicines,11e17 homeopathy18e24 and
physical techniques.25,26 However, few reports have focused on the
actual situation of CAM use for the treatment of allergic rhinitis.
We therefore performed the ﬁrst survey on this issue using a
questionnaire. The purpose of this study was to investigate the
actual situation of CAM practice in patients with allergic rhinitis, as
well as the reasons for CAM use, comparing the situation among
groups with different backgrounds.10 Had you ever experienced any adverse effects? [yes/no]
11 Tell me the contents of the adverse effects.
Table 2
Prevalence of CAM.
Total CAM practice Prevalence p-ValueMethods
Distribution and collection of the questionnaire
We distributed questionnaires to the otolaryngologists of 114
hospitals and clinics afﬁliated with the university of each author in
Japan. The subjects who participated in this study included children
<16 years of age and adults16 years of age diagnosedwith allergic
rhinitis by otolaryngologists. The survey was performed in the
period from September 2007 to August 2009. Furthermore, we
performed the same investigation outside of the hospital, such as
during general health examinations and open lecture meetings for
allergic rhinitis. All questionnaires were returned to Chiba Univer-
sity and analyzed. The study protocol was approved by the Ethics
Committee of Chiba University Hospital, and informed consent was
obtained from each subject.(No.) (No.) of CAM (%) (between the
genders)
Children (<16 yr) 3170 225 7.1% e
16 yre20s Female 1027 174 16.9% p < .01
Male 605 69 11.4%
Total 1632 243 14.9% e
30s Female 1144 309 27.0% p < .05
Male 495 104 21.0%
Total 1639 413 25.2% e
40s Female 1013 267 26.4% p < .001
Male 465 84 18.1%
Total 1478 351 23.7% e
50s Female 829 183 22.1% p < .01
Male 413 64 15.5%Content of the questionnaire
The details of the questions in the questionnaire are shown in
Table 1. The current study focused on the prevalence of CAM use,
type of CAM, period and efﬁcacy of a CAM treatment which was
used for the longest time, expense, reason for CAM use, provider of
information, consultation with the physician and adverse effects.
The questionnaires were ﬁlled out by the patients. When the chil-
dren were too young to ﬁll out the questionnaire, their parents
completed the form.Total 1242 247 19.9% e
60se80s Female 748 106 14.2% p < .01
Male 624 56 9.0%
Total 1372 162 11.8% e
Total of
adults
Female 4761 1039 21.8% p < .001
Male 2602 377 14.5%
Total 7363 1416 19.2% eStatistical analysis
All datawere analyzed at Chiba University. The data analysis was
performed using the chi-square test at a signiﬁcance level of 5%.Please cite this article in press as: Yonekura S, et al., Complementary
International (2016), http://dx.doi.org/10.1016/j.alit.2016.10.006Results
Answers of the patients who visited the hospitals
A total of 10,533 patients with AR completed the questionnaire.
Prevalence of CAM (Question 1)
Table 2 shows the prevalence of CAM use according to age and
gender. The proportions of patients who had ever experimentedand alternative medicine for allergic rhinitis in Japan, Allergology
Table 3
Answers in patients who visited otolaryngologists.
Adults
n ¼ 1416
Children
n ¼ 225
Types of CAM
Phytotherapy
Ten-Cha (Rubus suavissimus) 38.8% 20.9%
Chameleon plant tea (Houttuynia cordata) 3.9% 0.9%
Guava tea (Psidium guajava) 3.2% 0.4%
Japanese Green tea (Camellia sinensis) 2.3% 1.3%
S. Yonekura et al. / Allergology International xxx (2016) 1e7 3with CAM were 19.2% (1416/7363) and 7.1% (225/3170) in adults
and children, respectively. Adults used CAM more frequently than
children, and signiﬁcant difference was observed (p < .001). Among
the adult patients, 4761 females and 2602 males answered the
questionnaires. The prevalence of CAM use was 21.8% and 14.5% in
females and males, respectively. When compared between the
genders, the rates were signiﬁcantly higher in the female patients
than in the male patients at all ages. The peak rates were observed
in the patients in their 30se50s in both genders.Japanese persimmon tea (Diospyros kaki) 2.1% 1.3%
Gymnema tea (Gymnema sylvestre) 1.0% 0%
Herb tea (The content is unclear) 4.7% 0.9%
Shiso (Perilla frutescens) 11.8% 6.2%
Green juice 2.6% 2.7%
Chlorella 1.8% 0.4%
Aloe 1.8% 0.9%
Physical techniques
Acupuncture 1.9% 1.3%
Moxibustion 1.1% 0%
Qigong 0.7% 0.4%
Other treatment by ingestion
Chinese medicine 9.2% 8.9%
Foods containing lactic acid bacteria (such as
yogurt)
32.4% 22.7%
Cedar pollen candy 14.2% 3.6%
Mint gum 11.0% 1.8%
Tablet containing lactic acid bacteria 5.1% 2.7%
Propolis 3.6% 1.3%
Other therapies
Nose steam therapy 7.5% 9.3%
Aromatherapy 3.2% 3.6%Types of CAM (Question 2)
The types of CAM are shown in Table 3. Sixty two percent of
patients had ever used only one type of CAM, whereas the
remaining 38% had used multiple CAM therapies. The frequency of
Ten-Cha was 38.8%, which was the highest among all treatments in
the adult patients. The rate of consumption of foods containing
lactic acid bacteria (such as yogurt) was 32.4%, which was the
second highest. The rates of use of Cedar pollen candy, Shiso (Perilla
frutescens) and Mint gum each exceeded 10%. Treatment with rates
above 5% included Chinesemedicine and nose steam therapy. Other
treatments were used at rates of less than 5%. The rates of
consuming foods containing lactic acid bacteria (such as yogurt)
and Ten-Cha were 22.7% and 20.9%, respectively, which were the
highest among all treatments in children. The rates of nose steam
therapy, Chinese medicine, and Shiso (P. frutescens) were above 5%
in the current study.Spa therapy 1.8% 1.8%
Others 8.5% 16.0%
Period
Less than one month 32.6% 35.1%
Approximately half one year 25.8% 27.2%
Approximately one year; 8.3% 5.3%
More than one year 26.0% 25.8%
Others 7.3% 6.6%
Efﬁcacy
Unknown 41.4% 48.7%
No effect 22.1% 15.0%
Slightly effective 29.2% 29.4%
Very effective 7.0% 6.3%
Others 0.3% 0.6%
Expense
Less than $10 12.0% 12.8%Period, efﬁcacy and expense (Questions 3e5)
The results for the treatment period and efﬁcacy of a CAM
treatment which was used for the longest time and expense are
shown in Table 3. The total rates of treatment duration of
“approximately one year” and “more than one year”were 34.3% and
31.1% in adults and children, respectively. The total rates of efﬁcacy
of “slightly effective” and “very effective” were 36.2% and 35.7% in
adults and children, respectively. In addition, the rates of patients
who had spent more than $1000 were 5.9% and 6.2% in adults and
children, respectively.$10e100 44.8% 39.4%
$100e1000 27.1% 35.4%
More than $1000 5.9% 6.2%
Others 10.2% 6.2%
Reason of CAM use
Few side effects 47.4% 47.1%
Convenience 22.6% 12.9%
Low price 17.2% 8.9%
Dissatisfaction with the treatment at the
hospital
8.5% 12.9%
Worry about the side effect of the treatment at
the hospital
5.5% 7.6%Reasons for CAM use (Question 6)
The reasons for CAM use are shown in Table 3. The most
frequent reasonwas “few side effects,” at a rate of 47.4% in the adult
patients. The second and third reasons were “convenience” and
“low price,” respectively. In children, the most popular reason was
also “few side effects,” at a rate of 47.1%. The second and third
reasons were “convenience” and “dissatisfaction with the treat-
ment at the hospital.”Insufﬁcient treatment explanation from the
physician
0.8% 0.9%
Others 27.8% 32.9%
Providers of CAM information
TV or newspaper 45.6% 31.6%
Family or friends 42.0% 47.6%
Health magazines 24.7% 20.9%
Website use 6.7% 7.6%
Physicians 3.9% 6.7%
Others 10.2% 9.8%
Consultation with a physician
yes 15.3% 14.0%
Reaction of physicians (Only patients who answered “yes”)
The Physician recommended to continue 14.8% 36.0%
The Physician encouraged to stop 6.6% 8.0%
No advice 78.6% 56.0%Provider of CAM information (Question 7)
The providers of CAM information are shown in Table 3. In adult
patients, the most common way of learning about CAM therapies
was through information obtained from the “TV or newspaper,” at a
rate of 45.6%. The second and third most popular ways were to
obtain information from “family or friends” and “health maga-
zines,” respectively. The rate of “website use” was not high. In
children, the most common way was to obtain information from
“family or friends,” at a rate of 47.6%, while the second and third
most popular ways were through the “TV or newspaper” and
“health magazines.”Please cite this article in press as: Yonekura S, et al., Complementary and alternative medicine for allergic rhinitis in Japan, Allergology
International (2016), http://dx.doi.org/10.1016/j.alit.2016.10.006
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The rate of consultation with a physician for CAM is shown in
Table 3. In adults, the proportion of patients who had talked
about their CAM therapies with a physician was 15.3%. Conversely,
the vast majority of respondents (84.7%) answered they had not
previously talked about their CAM treatments with a physician.
Among the 15.3% of patients who had talked with a physician,
6.6% were encouraged to stop using their CAM treatments. Almost
all of the patients (78.6%) received no advice from their physi-
cians, while 14.8% of the patients were recommended to continue
using their CAM treatments. In children, the proportion of pa-
tients who had talked about their CAM therapies with a physician
was 14.0%. Among the 14.0% of these patients, 8.0% were told to
stop using their CAM treatments. More than half of the patients
(56.0%) received no advice from their physicians, and 36.0% of the
patients were recommended to continue using their CAM
therapies.
Adverse effects (Questions 10 and 11)
Therewere eight adverse events associatedwith the use of CAM.
These adverse events included ﬁve cases of urticaria, two cases of
abdominal pain and one case of nausea. Cedar pollen candy caused
four cases of urticaria, while Chinese medicine caused urticaria and
nausea and both Ten-Cha and foods containing lactic acid bacteria
caused abdominal pain, respectively.
Comparison of seasonal and perennial allergic rhinitis in the adult
patients
Table 4 shows a comparison between the patients with seasonal
allergic rhinitis (SAR) and perennial allergic rhinitis (PAR). Ten-Cha
and foods containing lactic acid bacteria (such as yogurt) were the
most popular CAM treatments in the SAR group. On the other hand,
nose steam therapy and Chinese medicine were the most common
treatments in the PAR group. Regarding the period of CAM use, the
total rates of “approximately one year” and “more than one year”
were signiﬁcantly higher in the PAR group than in the SAR group
(p < .001). In terms of the efﬁcacy of CAM, the total rates of “slightly
effective” and “very effective” were signiﬁcantly higher in the PAR
group than in the SAR group (p < .001). Additionally, the proportion
of patients who spent more than $1000 was higher in the PARTable 4
Comparison between SAR and PAR.
Types of AR No. Types of CAM
SAR 942 Ten-Cha Foods containing lac
50.1% 42.1%
PAR 175 Nasal nebulizer Chinese medicine
20.6% 18.9%
Types of AR Period Efﬁca
Approximately one year or
longer than one year
p-Value (OR) Slight
effect
SAR 31.5% e 33.4%
PAR 49.6% <.001 (2.15) 46.6%
Types of AR Reason for CAM use
Few side
effects
Convenience Low
price
Dissatisfaction with the
treatment at the hospital
Worry about
of the treatm
at the hospita
SAR 48.5% 23.8% 17.8% 8.0% 5.6%
PAR 46.5% 16.2% 9.3% 10.0% 4.7%
AR, Allergic rhinitis; SAR, Seasonal allergic rhinitis; PAR, Perennial allergic rhinitis.
Please cite this article in press as: Yonekura S, et al., Complementary
International (2016), http://dx.doi.org/10.1016/j.alit.2016.10.006group and a tendency towards signiﬁcancewas observed (p¼ .058).
The proportion of patients who choose at least one of the following
three answers (“dissatisfaction with the treatment at the hospital,”
“worry about the side effects of the treatment at the hospital” and
“insufﬁcient treatment explanation from the physician”) was 10.7%
and 17.1% in the SAR and PAR groups, respectively. The patients
with PAR felt signiﬁcantly more dissatisfaction and anxiety related
to treatment at the hospital (p < .05).
Comparison of the groups who spent $1000 or more, or less than
$1000 on CAM among the adult patients
There were no differences the type of CAM between the groups
who spent $1000 or more (n¼ 83) or less than $1000 (n¼ 1188) on
CAM, and Ten-Cha, foods containing lactic acid bacteria and Chi-
nese medicine were the most popular CAM therapies in both
groups (data not shown). The group who spent $1000 or more on
CAM thought that the CAM treatments were more effective
(p < .05) and felt more dissatisfaction and anxiety related to
treatment at the hospital (p < .05) (Table 5).
Comparison of the subject groups with different backgrounds in the
adult patients
We performed the same questionnaire survey outside of the
hospital setting among subjects who received general health ex-
aminations or attended open public medical lecture meetings
(Table 6). A total of 762 subjects had previously received an AR
diagnosis at the hospital. Although the type of CAM was not
signiﬁcantly different compared with that observed in the AR pa-
tients examined at the hospital, the rate of CAM use was higher in
the subjects assessed outside of the hospital. As for the reasons for
CAM use, the rates of dissatisfaction and anxiety related to treat-
ment at the hospital were higher in these subjects (p < .001).
Discussion
We investigated whether patients who received treatment at
the hospital for allergic rhinitis (AR) had ever experienced therapy
with CAM. Consequently, we found that approximately 19% of the
adult patients and 7% of the pediatric patients had received treat-
ment with CAM. Despite their various experiences, the efﬁcacy of
CAM therapies, including mild effects was noted in approximatelytic acid bacteria Cedar pollen candy Shiso
18.6% 14.8%
Ten-Cha Foods containing lactic
acid bacteria
18.3% 17.1%
cy Cost
ly or very
ive
p-Value (OR) More than $1000 p-Value (OR)
e 4.1% e
<.001 (1.76) 7.5% 0.058 (1.86)
the side effect
ent
l
Insufﬁcient treatment
explanation from the
physician
Dissatisfaction and anxiety
related to treatment
at the hospital
p-Value (OR)
0.6% 10.7% e
3.1% 17.1% <.05 (1.72)
and alternative medicine for allergic rhinitis in Japan, Allergology
Table 5
Comparison between groups who had spent more or less than $1000 on CAMs.
Group of
expense
n Efﬁcacy Reason for CAM use
Slightly or
very
effective
p-Value
(OR)
Few side
effects
Convenience Low
price
Dissatisfaction
with the
treatment at the
hospital
Worry about
the side effect
of the treatment
at the hospital
Insufﬁcient
treatment
explanation from
the physician
Dissatisfaction
and anxiety related
to treatment
at the hospital
p-Value (OR)
Less than $1000 1188 34.7% e 43.5% 21.2% 16.3% 7.7% 4.6% 0.6% 12.6% e
More than $1000 83 46.8% <.05 (1.67) 57.7% 17.3% 9.6% 11.5% 13.5% 1.9% 21.2% <.05 (1.92)
Table 6
Comparison between different background groups.
Backgrounds Prevalence of CAM Type of CAM
Total No. CAM practice n (%) p-Value (OR)
Hospital 7363 1416 (19.2) e Ten-Cha Foods containing lactic acid bacteria Cedar pollen candy Shiso
38.8% 32.4% 14.2% 11.8%
Outside of the
hospital
762 348 (45.7) <.001 (3.53) Foods containing lactic
acid bacteria
Ten-Cha Cedar pollen candy Shiso
44.8% 42.8% 17.0% 16.1%
Backgrounds Period Efﬁcacy Expense
Approximately one year or
longer than one year
p-Value (OR) Slightly or very effective p-Value (OR) More than $1000 p-Value (OR)
Hospital 34.3% e 36.2% e 5.9% e
Outside of the
hospital
40.0% <.05 (1.27) 43.8% <.05 (1.37) 39.2% <.001 (10.2)
Backgrounds Reason for CAM use
Few side
effects
Convenience Low
price
Dissatisfaction with the
treatment at the hospital
Worry about the side
effect of the treatment
at the hospital
Insufﬁcient treatment
explanation from
the physician
Dissatisfaction and
anxiety related to
treatment at the hospital
p-Value (OR)
Hospital 47.4% 22.6% 17.2% 8.5% 5.5% 0.8% 14.9% e
Outside of the
hospital
55.1% 22.1% 12.3% 16.3% 11.2% 2.9% 27.9% <.001 (2.21)
S. Yonekura et al. / Allergology International xxx (2016) 1e7 536% of the patients, with no clear effects in the remaining 60% or
more of patients. The low percentage of patients who underwent
CAM therapy may be related to the fact that such patients visited
the hospital regularly.
On the other hand, in studies performed at facilities outside of
the hospitals, such as during general health examinations, the
percentage of use of CAM was 52.6%, which was higher than that
noted in the hospital patients, and the percentage of patients who
judged CAM therapy as being efﬁcacious was also high (43.8%).
Although the high percentage of use of CAM reﬂected the efﬁcacy of
alternative medicine treatment in these patients, the subjects had
been diagnosed and treated for AR at the hospital at least once. The
reasons for use of CAM in these patients included safety, insufﬁ-
cient effects of treatment provided by medical facilities and con-
cerns about the side effects of the treatments provided by medical
facilities. Anxiety, insufﬁcient treatment effects at medical facilities
and the inconvenience of visiting the hospital were also common
reasons among the patients whose spending on CAM was high.
These ﬁndings are different from those of a previous survey that
focused on reasons for CAM use,27 in which the majority of CAM
users were not dissatisﬁed with conventional medicine, but rather
used CAM largely because of their own values, beliefs and philo-
sophical orientations toward health and life. One of the reasons for
the differences between our ﬁndings and those of previous surveys
was the exclusion of patient values, beliefs, and philosophical
orientation from the questionnaire used in the present study.
Further investigation is warranted to determine whether these
factors were contributors to CAM use in Japanese patients.
It is difﬁcult to evaluate the efﬁcacy of CAM treatments.
Comparative studies have been performed to assess variousPlease cite this article in press as: Yonekura S, et al., Complementary
International (2016), http://dx.doi.org/10.1016/j.alit.2016.10.006alternative medicine therapies8e26 in AR. Recent studies on CAM
therapy for AR and respiratory disorders28,29 indicated that
acupuncture, herbal medicines, and homeopathy remain popular to
this day. Phototherapy, which was not included in our question-
naire as it is rarely used in Japan, is a relatively new treatment that
was evaluated by several studies.30,31 Although improvements in
symptoms have been reported in some studies that included
comparisons with a placebo group or sham
treatment,8,9,11e13,18e20,25,26 the details of such comparative studies,
including the evaluation methods and investigators, were not dis-
cussed sufﬁciently. Therefore, the evidence inmany of these studies
is insufﬁcient. Although high efﬁcacy has been reported in some
studies, additional studies were unable to conﬁrm these results.
CAM therapies are alsowidely used by patients with asthma and
atopic dermatitis.32,33 Many patients with asthma use acupuncture,
herbal medicines, homeopathy, and breathing techniques.32 A
recent review33 of CAM for atopic dermatitis showed evidence
supporting the use of acupuncture and acupressure, stress-
reducing techniques, balneotherapy, herbal medicines, topical ap-
plicants, dietary therapy, and health supplements. While some of
these approaches might be effective, evidence supporting the ef-
ﬁcacy of CAM in these allergic diseases is not consistent, similar to
that observed for AR. Recent studies assessing the efﬁcacy of CAM
for asthma emphasized that CAM endorsement was associated
with negative standard treatment beliefs, uncontrolled asthma, and
poorer health-related quality of life.34,35
On the other hand, many comparative studies have been per-
formed of standard treatments, including meta-analyses, and the
considerable placebo effect has attracted much attention in such
studies. Since there are no objective biomarkers of the effects onand alternative medicine for allergic rhinitis in Japan, Allergology
S. Yonekura et al. / Allergology International xxx (2016) 1e76AR, the therapeutic effects must be evaluated subjectively by the
patients. It is widely known that assessing the therapeutic effects in
AR patients is not easy because of the high rate of the placebo
effect.36e38 The effects of CAM are believed to be due to the placebo
effect inmany cases. However, it is also difﬁcult to demonstrate that
CAM treatments do not have any effects.
Based on the results of this investigation of CAM therapies,
CAM treatments may be selected by patients as a result of insuf-
ﬁcient knowledge regarding standard treatments. Although do-
mestic and international guidelines are available, information on
the importance, effects and safety of standard treatments may be
insufﬁcient for most patients as well as general physicians. The
development of highly efﬁcacious treatment methods would
obviously be useful; however, it is also important to clearly show
the importance of the present standard treatments. The health
insurance system in Japan covers all citizens, and patients have an
obligation to pay 30% of medical expenses in the system. Although
it should be clariﬁed why patients do not receive ordinary drug
therapy, most of the patients in our study had visited the hospital
and had received treatment for AR at least once. The lack of a
sufﬁcient explanation from the physician and/or strong commu-
nication with the patient might lead to dissatisfaction and anxiety
against these treatments. More than half of the patients in our
series who consulted with a physician about CAM were unable to
receive advice on this issue. At present, physicians do not have
sufﬁcient information on CAM to be able to provide effective
advice to the patients as the efﬁcacy of most CAM therapies has
not yet been objectively evaluated.
The results of this investigation showed that approximately 19%
of the AR patients who were receiving treatment at a medical fa-
cility had received CAM therapies, although their evaluation of CAM
treatments was not high. However, the assessment of patients
whose spending on CAM was high and AR patients who did not
continue to receive treatment at medical facilities showed high
consultation rates and high evaluation rates for CAM treatments.
These patients received CAM therapies because they felt that the
effects of the treatments provided by the hospitals were insufﬁcient
and had concerns about the side effects of such treatments. On the
other hand, about half of the patients whose spending on CAMwas
high were not satisﬁed with the results. Among the potential rea-
sons for this outcome are the lack of superiority of these CAM
therapies over standard treatments and very high expectations of
CAM therapies. Information regarding standard treatments, as
described in the guidelines, must become widely known and
diffused among AR patients as well as physicians who are not
specialized in treating allergies, and strong communication with
patients should be considered.Acknowledgements
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